NO20025031D0 - Benzoksazin- og benzotiazinderivater og anvendelsen derav i medikamenter - Google Patents

Benzoksazin- og benzotiazinderivater og anvendelsen derav i medikamenter

Info

Publication number: NO20025031D0
Authority: NO; Norway
Prior art keywords: benzoxazine; drugs; benzothiazine derivatives; benzothiazine; derivatives
Prior art date: 2000-04-19

Application number

NO20025031A

Other languages

English (en)

Other versions

NO20025031L (no

Inventor

Hartmut Rehwinkel

Peter Hoelscher

Stefan Jaroch

Detlev Suelzle

Margrit Hillmann

Gerardine Anne Burton

Fiona Mcdougall Mcdonald

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-19

Filing date

2002-10-18

Publication date

2002-10-18

2002-10-18 Application filed by Schering Ag filed Critical Schering Ag

2002-10-18 Publication of NO20025031D0 publication Critical patent/NO20025031D0/no

2002-12-19 Publication of NO20025031L publication Critical patent/NO20025031L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Hematology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Dermatology (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

NO20025031A 2000-04-19 2002-10-18 Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasöytiske midler NO20025031L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10020667A DE10020667A1 (de)	2000-04-19	2000-04-19	Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
PCT/EP2001/004281 WO2001081323A1 (de)	2000-04-19	2001-04-12	Benzoxazin- und benzothiazin-derivate und deren verwendung in arzneimitteln

Publications (2)

Publication Number	Publication Date
NO20025031D0 true NO20025031D0 (no)	2002-10-18
NO20025031L NO20025031L (no)	2002-12-19

Family

ID=7640119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025031A NO20025031L (no)	2000-04-19	2002-10-18	Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasöytiske midler

Country Status (8)

Country	Link
US (1)	US6914059B2 (no)
EP (1)	EP1282610B1 (no)
JP (1)	JP2003531198A (no)
AT (1)	ATE368033T1 (no)
AU (1)	AU2001256294A1 (no)
DE (2)	DE10020667A1 (no)
NO (1)	NO20025031L (no)
WO (1)	WO2001081323A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998050372A1 (de) *	1997-05-02	1998-11-12	Schering Aktiengesellschaft	Substituierte heterocyclen und deren verwendung in arzneimitteln
WO1999012915A1 (de) *	1997-09-08	1999-03-18	Schering Aktiengesellschaft	Benzoxazin- und benzothiazin-derivate und deren verwendung in arzneimitteln
DE19806348A1 (de)	1998-02-12	1999-08-19	Schering Ag	3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln
DE19844291A1 (de) *	1998-09-18	2000-03-23	Schering Ag	Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
DE19941115A1 (de) *	1999-08-25	2001-03-01	Schering Ag	Neue Benzoxazin- und Bezothiazin-Derivate und deren Verwendung in Arzneimitteln

2000
- 2000-04-19 DE DE10020667A patent/DE10020667A1/de not_active Ceased
2001
- 2001-04-12 DE DE50112766T patent/DE50112766D1/de not_active Expired - Fee Related
- 2001-04-12 US US10/258,016 patent/US6914059B2/en not_active Expired - Fee Related
- 2001-04-12 WO PCT/EP2001/004281 patent/WO2001081323A1/de not_active Ceased
- 2001-04-12 AU AU2001256294A patent/AU2001256294A1/en not_active Abandoned
- 2001-04-12 EP EP01929561A patent/EP1282610B1/de not_active Expired - Lifetime
- 2001-04-12 AT AT01929561T patent/ATE368033T1/de not_active IP Right Cessation
- 2001-04-12 JP JP2001578416A patent/JP2003531198A/ja active Pending
2002
- 2002-10-18 NO NO20025031A patent/NO20025031L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20040006075A1 (en)	2004-01-08
DE50112766D1 (de)	2007-09-06
AU2001256294A1 (en)	2001-11-07
EP1282610A1 (de)	2003-02-12
JP2003531198A (ja)	2003-10-21
EP1282610B1 (de)	2007-07-25
NO20025031L (no)	2002-12-19
WO2001081323A1 (de)	2001-11-01
DE10020667A1 (de)	2001-11-22
ATE368033T1 (de)	2007-08-15
US6914059B2 (en)	2005-07-05

Publication	Publication Date	Title
MX2007000505A (es)	2007-06-25	Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
ATE302775T1 (de)	2005-09-15	Carbolinderivate
ATE260275T1 (de)	2004-03-15	Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
TW200502230A (en)	2005-01-16	Dual nk1/nk3 derivatives
ATE450533T1 (de)	2009-12-15	Carboxamidderivate
DE60132975D1 (de)	2008-04-10	Neue substanzen und verbindungen als protease-inhibitoren
UY26926A1 (es)	2002-03-22	Derivados de la quinolina y quinazolina
NO20044731L (no)	2004-12-30	Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
EA200601686A1 (ru)	2007-02-27	Замещенные производные морфолина и тиоморфолина
EP1508570A4 (en)	2007-08-15	NEW PHYSIOLOGICAL ACTIVE SUBSTANCES
TR200200795T2 (tr)	2002-07-22	5-HT1B antagonistleri olarak piperazin türevleri
ATE416157T1 (de)	2008-12-15	Inhibitoren von integrin alpha-v-beta-6
NO20062020L (no)	2006-07-10	1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
ATE346067T1 (de)	2006-12-15	Carbolinderivate
ATE422198T1 (de)	2009-02-15	Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten
ATE449069T1 (de)	2009-12-15	Aminopropanolderivate
ATE347555T1 (de)	2006-12-15	6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
TR200100895T2 (tr)	2001-12-21	Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
UY27018A1 (es)	2002-06-20	Derivados de la pirimidina
DE60115466D1 (de)	2006-01-05	Wirkstoffvorläufer von imidazopyridin-derivaten
ATE287886T1 (de)	2005-02-15	Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer
DE60112960D1 (de)	2005-09-29	Kondensierte pyridoindolderivate
ATE259813T1 (de)	2004-03-15	Triazolopyrimidinderivate
ATE330958T1 (de)	2006-07-15	Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
TR200000637T2 (tr)	2000-07-21	Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.

Legal Events

Date	Code	Title	Description
2006-11-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application